| 名稱(chēng) | hIL21 Effector Reporter Cell |
| 型號(hào) | CBP74183 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | hIL5 Effector Reporter Cell |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 熱門(mén)CTLA4&PD1/L1雙靶點(diǎn)抗體活性檢測(cè)細(xì)胞模型
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- 細(xì)胞株的STR鑒定技術(shù)分享
- 針對(duì)ctDNA的MRD檢測(cè)，你參與了嗎？
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 剛收到的細(xì)胞株如何進(jìn)行合理的處理？
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 【靶點(diǎn)模型+診斷質(zhì)控】BTK C481S的藥物開(kāi)發(fā)和診斷
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74183hIL21 Effector Reporter Cell
- 詳細(xì)內(nèi)容
<
| CBP74183 | |
| I. Background | |
| IL21 (Interleukin 21) is a Protein Coding gene. Diseases associated with IL21 include Immunodeficiency, Common Variable, 11 and Severe Combined Immunodeficiency, X-Linked. | |
| II. Introduction | |
| Expressed gene: | IL21R |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | IL-21, Za11, interleukin 21, IL21, Il21; |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+2ug/ml puromycin+200ug/ml hygromycin+5ug/ml blasticidin+400ug/ml G418 |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
Figure 1. Recombinant hIL21 Effector Reporter Cell constitutively expressing IL21R. | |
Figure 2.Dose Response of Recombinant Human IL21 in hlL21 Effector Reporter Cells (C11). | |
Figure 3.Inhibition of hIlL21-Induced Reporter Activity by lL21 Neutralization Ab in hlL21 Effector Reporter Cells (C11). | |
會(huì)員_a.png)